Abstract
United States Diabetes Care Devices Investment Opportunities, Analysis and
Forecasts to 2012
Summary
This report is an essential source for in-depth information and data relating
to the USA diabetes care devices market. It also offers detailed and
comprehensive coverage of market revenue, volume, distribution and company
share information; and latest news, financial deals and pipeline products
information of each of the key sub-segments of the diabetes care devices in
USA
Scope
・ The report provides diabetes care devices information broken down into
detailed categories and segments in United States.
・ Total revenues,
products sold, end users, and average pricing.
・ Market shares of all the
key competitors.
・ Key pipeline products that are set to shape the
market, broken down by sector.
・ Information on the top medical equipment
companies in the sector in the country covering business description,
strategic analysis, and financial information.
・ Healthcare structure,
regulatory environment, approval process, pricing trends and
reimbursement.
・ Product and brand updates, strategy changes, R&D
projects, corporate expansions and contractions and regulatory changes.
・
Key mergers and acquisitions, partnerships, private equity investments and
IPOs.
・ Customer, hospitals and physicians data.
Reasons to buy
・ Gain a strong understanding of the diabetes care devices market in United
States.
・ Evaluate and compare the attractiveness of the market in the
country.
・ Identify growth segments and opportunities in each industry
sector within the country.
・ Evaluate the pipeline of key products that
will change the sector, and identify threats and opportunities before the
products are launched in the country.
・ Analyze the competitiveness of the
market in the country and identify hotspots.
・ Develop strategies based
on the latest product, brand, expansion and research and development news in
the country.
・ Do deals with an understanding of how competitors are
financed, and the mergers and partnerships that have shaped the market in the
country.
・ Identify and analyze the strengths and weaknesses of the
industry incumbents in the country.
Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 10
2 Introduction 12
2.1 What Is This Report About? 12
2.2 Definitions
12
3 Healthcare Sector Review 14
3.1 Healthcare Expenditure 14
3.2
Healthcare Infrastructure 19
4 Diabetes Care Devices in United States
26
4.1 Diabetes Care Devices Overall Revenues (2000-2012) 26
4.2
Diabetes Care Devices Overall Volume (2000-2012) 32
4.3 Diabetes Care
Devices Overall Company Share (2005-2006) 35
5 Glucose Monitoring in
United States 36
5.1 Glucose Monitoring Overall Revenues (2000-2012)
36
5.2 Glucose Monitoring Overall Volume (2000-2012) 44
5.3 Glucose
Monitoring Average Price (2000-2012) 49
5.4 Glucose Monitoring
Distribution Share (2005-2006) 53
5.5 Glucose Monitoring Company Share
(2005-2006) 54
6 Insulin Delivery in United States 55
6.1 Insulin
Delivery Overall Revenues (2000-2012) 55
6.2 Insulin Delivery Overall
Volume (2000-2012) 67
6.3 Insulin Delivery Average Price (2000-2012)
76
6.4 Insulin Delivery Distribution Share (2005-2006) 84
6.5 Insulin
Delivery Company Share (2005-2006) 85
7 F. Hoffmann-La Roche Ltd. Company
Profile 86
7.1 Company Overview 86
7.2 Business Overview 86
7.3
Value Chain Analysis 90
7.4 SWOT Analysis 92
7.5 Financial and
Operational Review 96
7.6 Locations And Subsidiaries 98
8 LifeScan,
Inc. Company Profile 101
8.1 Company Overview 101
8.2 Business
Overview 101
8.3 Locations And Subsidiaries 102
8.4 LifeScan, Inc.
Pipeline Products 103
9 Abbott Laboratories Company Profile 106
9.1
Company Overview 106
9.2 Business Overview 106
9.3 Value Chain
Analysis 111
9.4 SWOT Analysis 113
9.5 Financial and Operational
Review 117
9.6 Locations And Subsidiaries 119
9.7 Abbott Laboratories
Pipeline Products 121
10 Novo Nordisk A/S Company Profile 129
10.1
Company Overview 129
10.2 Business Overview 129
10.3 Locations And
Subsidiaries 130
10.4 Novo Nordisk A/S Pipeline Products 133
11
Becton, Dickinson Company Profile 135
11.1 Company Overview 135
11.2
Business Overview 135
11.3 Value Chain Analysis 139
11.4 SWOT Analysis
140
11.5 Financial and Operational Review 145
11.6 Locations And
Subsidiaries 147
12 Regulation System 149
12.1 Regulation System
149
12.2 Medical Equipment Approval Process 149
13 Pricing and
Reimbursement 156
13.1 Government Policies 156
13.2 Private Insurance
157
13.3 Diagnosis Related Groups (DRG) 158
14 Distribution Structure
159
14.1 Distribution Structure 159
15 Financial Deals Landscape
160
15.1 Acquisition 160
15.2 Private Equity 162
15.3 Venture
Financing 163
15.4 IPO 176
15.5 Debt Offerings 177
15.6
Partnership 183
16 Recent Developments 189
16.1 Strategy And Business
Planning 189
16.2 Corporate Communications 190
16.3 Legal and
Regulatory 199
16.4 Government and Public Interest 200
16.5 Product
News 204
16.6 Clinical Trials 205
17 Appendix 206
17.1 Global
Markets Direct Research Methodology 206
17.2 Coverage 207
17.3
Secondary Research 207
17.4 Primary Research 208
17.5 Models 208
17.6 Forecasts 209
17.7 Expert Panels 209
17.8 Currency Conversion
210
17.9 Contact Us 211
17.10 Disclaimer 211
1.1 List of
Tables
Table 1: United States Healthcare Expenditure, 2003-2010 19
Table 2: United States Healthcare Expenditure by Age (per person), 2000-2003
20
Table 3: United States Healthcare Expenditure by Sex (per person),
2000-2003 20
Table 4: United States Healthcare Expenditure by Race (per
person), 2000-2003 20
Table 5: United States Personal Healthcare
Expenditure by Type, 2000-2004 21
Table 6: United States Personal
Healthcare Expenditure by Source, 2000-2004 22
Table 7: Total Number of
Doctors in the United States, 2003-2010 25
Table 8: Number of Doctors by
Specialty in the United States, 2003-2010 26
Table 9: Doctors by Region
(Number per 10,000 Civilian Population), 2002-2004 27
Table 10: Doctors by
Region (Number per 10,000 Civilian Population), 2002-2004 (Cont.) 28
Table
11: Total Hospitals in the United States, 2000-2004 28
Table 12: Community
Hospitals by Number of Beds in the United States, 2000-2004 29
Table 13:
Number of Hospital Beds in the United States, 2000-2004 29
Table 14:
Number of Hospital Beds by Range in the United States, 2000-2004 29
Table
15: Diabetes Care Devices, United States, Overall Revenues ($ mn), 2000-2012
30
Table 16: Diabetes Care Devices, United States, Overall Revenues ($
mn), Historic, 2000-2007 31
Table 17: Diabetes Care Devices, United
States, Overall Revenues ($ mn), Forecast, 2007-2012 32
Table 18: Diabetes
Care Devices, United States, Category Revenues ($ mn), 2000-2012 33
Table
19: Diabetes Care Devices, United States, Category Revenues ($ mn), Historic,
2000-2007 34
Table 20: Diabetes Care Devices, United States, Category
Revenues ($ mn), Forecast, 2007-2012 35
Table 21: Diabetes Care Devices,
United States, Category Volume (Units), 2000-2012 36
Table 22: Diabetes
Care Devices, United States, Category Volume (Units), Historic, 2000-2007
37
Table 23: Diabetes Care Devices, United States, Category Volume
(Units), Forecast, 2007-2012 38
Table 24: Table 25: Diabetes Care Devices,
United States, Overall Company Share by Revenue ($ mn) 2005-2006 39
Table
26: Glucose Monitoring, United States, Overall Revenues ($ mn), Historic,
2000-2007 40
Table 27: Glucose Monitoring, United States, Overall Revenues
($ mn), Forecast, 2007-2012 41
Table 28: Glucose Monitoring, United
States, Revenue by Segment ($ mn), Historic, 2000-2007 42
Table 29:
Glucose Monitoring, United States, Revenue by Segment ($ mn), Forecast,
2007-2012 43
Table 30: Blood Glucose Test Strips, United States, Overall
Revenues ($ mn), Historic, 2000-2007 44
Table 31: Blood Glucose Test
Strips, United States, Overall Revenues ($ mn), Forecast, 2007-2012 45
Table 32: Blood Glucose Meters, United States, Overall Revenues ($ mn),
Historic, 2000-2007 46
Table 33: Blood Glucose Meters, United States,
Overall Revenues ($ mn), Forecast, 2007-2012 47
Table 34: Glucose
Monitoring, United States, Overall Volume (Units), Historic, 2000-2007 48
Table 35: Glucose Monitoring, United States, Overall Volume (Units), Forecast,
2007-2012 48
Table 36: Blood Glucose Test Strips, United States, Overall
Volume (Units), Historic, 2000-2007 49
Table 37: Blood Glucose Test
Strips, United States, Overall Volume (Units), Forecast, 2007-2012 50
Table 38: Blood Glucose Meters, United States, Overall Volume (Units),
Historic, 2000-2007 51
Table 39: Blood Glucose Meters, United States,
Overall Volume (Units), Forecast, 2007-2012 52
Table 40: Blood Glucose
Meters, United States, Average Price ($), Historic, 2000-2007 53
Table 41:
Blood Glucose Meters, United States, Average Price ($), Forecast, 2007-2012
54
Table 42: Blood Glucose Test Strips, United States, Average Price ($),
Historic, 2000-2007 55
Table 43: Blood Glucose Test Strips, United States,
Average Price ($), Forecast, 2007-2012 56
Table 44: Glucose Monitoring,
United States, Distribution Share by Revenue ($ mn), 2005-2006 57
Table
45: Glucose Monitoring, United States, Company Share by Revenue ($ mn),
2005-2006 58
Table 46: Insulin Delivery, United States, Overall Revenues
($ mn), Historic, 2000-2007 59
Table 47: Insulin Delivery, United States,
Overall Revenues ($ mn), Forecast, 2007-2012 60
Table 48: Insulin
Delivery, United States, Revenue by Segment ($ mn), Historic, 2000-2007 61
Table 49: Insulin Delivery, United States, Revenue by Segment ($ mn),
Forecast, 2007-2012 62
Table 50: Insulin Syringes, United States, Overall
Revenues ($ mn), Historic, 2000-2007 63
Table 51: Insulin Syringes, United
States, Overall Revenues ($ mn), Forecast, 2007-2012 64
Table 52: Insulin
Pumps, United States, Overall Revenues ($ mn), Historic, 2000-2007 65
Table 53: Insulin Pumps, United States, Overall Revenues ($ mn), Forecast,
2007-2012 66
Table 54: Insulin Pens, United States, Overall Revenues ($
mn), Historic, 2000-2007 67
Table 55: Insulin Pens, United States, Overall
Revenues ($ mn), Forecast, 2007-2012 68
Table 56: Insulin Jet Injectors,
United States, Overall Revenues ($ mn), Historic, 2000-2007 69
Table 57:
Insulin Jet Injectors, United States, Overall Revenues ($ mn), Forecast,
2007-2012 70
Table 58: Insulin Delivery, United States, Overall Volume
(Units), Historic, 2000-2007 71
Table 59: Insulin Delivery, United States,
Overall Volume (Units), Forecast, 2007-2012 71
Table 60: Insulin Syringes,
United States, Overall Volume (Units), Historic, 2000-2007 72
Table 61:
Insulin Syringes, United States, Overall Volume (Units), Forecast, 2007-2012
73
Table 62: Insulin Pumps, United States, Overall Volume (Units),
Historic, 2000-2007 74
Table 63: Insulin Pumps, United States, Overall
Volume (Units), Forecast, 2007-2012 75
Table 64: Insulin Pens, United
States, Overall Volume (Units), Historic, 2000-2007 76
Table 65: Insulin
Pens, United States, Overall Volume (Units), Forecast, 2007-2012 77
Table
66: Insulin Jet Injectors, United States, Overall Volume (Units), Historic,
2000-2007 78
Table 67: Insulin Jet Injectors, United States, Overall
Volume (Units), Forecast, 2007-2012 79
Table 68: Insulin Jet Injectors,
United States, Average Price ($), Historic, 2000-2007 80
Table 69: Insulin
Jet Injectors, United States, Average Price ($), Forecast, 2007-2012 81
Table 70: Insulin Pens, United States, Average Price ($), Historic, 2000-2007
82
Table 71: Insulin Pens, United States, Average Price ($), Forecast,
2007-2012 83
Table 72: Insulin Pumps, United States, Average Price ($),
Historic, 2000-2007 84
Table 73: Insulin Pumps, United States, Average
Price ($), Forecast, 2007-2012 85
Table 74: Insulin Syringes, United
States, Average Price ($), Historic, 2000-2007 86
Table 75: Insulin
Syringes, United States, Average Price ($), Forecast, 2007-2012 87
Table
76: Insulin Delivery, United States, Distribution Share by Revenue ($ mn),
2005-2006 88
Table 77: Insulin Delivery, United States, Company Share by
Revenue ($ mn), 2005-2006 89
Table 78: F. Hoffmann-La Roche Ltd.,
SWOT Analysis, 2006 97
Table 79: F. Hoffmann-La Roche Ltd., Financial
Statements, CHF Million, 2002-2006 100
Table 80: F. Hoffmann-La Roche
Ltd., Financial Ratios, CHF Million, 2002-2006 101
Table 81: F.
Hoffmann-La Roche Ltd., Other Locations 103
Table 82: F. Hoffmann-La
Roche Ltd., Subsidiaries 104
Table 83: LifeScan, Inc., Other
Locations 107
Table 84: Abbott Laboratories, SWOT Analysis, 2006
117
Table 85: Abbott Laboratories, Financial Statements, USD
Thousand, 2002-2006 121
Table 86: Abbott Laboratories, Financial
Ratios, USD Thousand, 2002-2006 122
Table 87: Abbott Laboratories,
Share Holding Structure 123
Table 88: Abbott Laboratories, Other
Locations 124
Table 89: Abbott Laboratories, Subsidiaries 124
Table 90: Novo Nordisk A/S, Other Locations 135
Table 91: Novo
Nordisk A/S, Subsidiaries 136
Table 92: Becton, Dickinson and
Company, SWOT Analysis, 2006 145
Table 93: Becton, Dickinson and
Company, Financial Statements, USD Thousand, 2002-2006 149
Table 94:
Becton, Dickinson and Company, Financial Ratios, USD Thousand, 2002-2006
150
Table 95: Becton, Dickinson and Company, Share Holding Structure
151
Table 96: Becton, Dickinson and Company, Other Locations 152
Table 97: Medical Equipment Registration Fee in United States, 2007 159
Table 98: Medical Device Approval Time in United States, 2004 159
Table
99: Currency Conversion from USD to Local Currency at 2007 Constant Rate
214
1.2 List of Figures
Figure 1: United States, Healthcare
Expenditure by Source, 2003 19
Figure 2: United States, Healthcare
Infrastructure, Top Level View, 2007 24
Figure 3: Healthcare Expenses
Segmentation by End User, 2003 25
Figure 4: Diabetes Care Devices, United
States, Overall Revenues ($ mn), 2000-2012 30
Figure 5: Diabetes Care
Devices, United States, Overall Revenues ($ mn), Historic, 2000-2007 31
Figure 6: Diabetes Care Devices, United States, Overall Revenues ($ mn),
Forecast, 2007-2012 32
Figure 7: Diabetes Care Devices, United States,
Category Revenues ($ mn), 2000-2012 33
Figure 8: Diabetes Care Devices,
United States, Category Revenues ($ mn), Historic, 2000-2007 34
Figure 9:
Diabetes Care Devices, United States, Category Revenues ($ mn), Forecast,
2007-2012 35
Figure 10: Diabetes Care Devices, United States, Category
Volume (Units), 2000-2012 36
Figure 11: Diabetes Care Devices, United
States, Category Volume (Units), Historic, 2000-2007 37
Figure 12:
Diabetes Care Devices, United States, Category Volume (Units), Forecast,
2007-2012 38
Figure 13: Diabetes Care Devices, United States, Overall
Company Share (%), 2006 39
Figure 14: Glucose Monitoring, United States,
Overall Revenues ($ mn), Historic, 2000-2007 40
Figure 15: Glucose
Monitoring, United States, Overall Revenues ($ mn), Forecast, 2007-2012 41
Figure 16: Glucose Monitoring, United States, Revenue by Segment ($ mn),
Historic, 2000-2007 42
Figure 17: Glucose Monitoring, United States,
Revenue by Segment ($ mn), Forecast, 2007-2012 43
Figure 18: Blood Glucose
Test Strips, United States, Overall Revenues ($ mn), Historic, 2000-2007
44
Figure 19: Blood Glucose Test Strips, United States, Overall Revenues
($ mn), Forecast, 2007-2012 45
Figure 20: Blood Glucose Meters, United
States, Overall Revenues ($ mn), Historic, 2000-2007 46
Figure 21: Blood
Glucose Meters, United States, Overall Revenues ($ mn), Forecast, 2007-2012
47
Figure 22: Blood Glucose Test Strips, United States, Overall Volume
(Units), Historic, 2000-2007 49
Figure 23: Blood Glucose Test Strips,
United States, Overall Volume (Units), Forecast, 2007-2012 50
Figure 24:
Blood Glucose Meters, United States, Overall Volume (Units), Historic,
2000-2007 51
Figure 25: Blood Glucose Meters, United States, Overall
Volume (Units), Forecast, 2007-2012 52
Figure 26: Blood Glucose Meters,
United States, Average Price ($), Historic, 2000-2007 53
Figure 27: Blood
Glucose Meters, United States, Average Price ($), Forecast, 2007-2012 54
Figure 28: Blood Glucose Test Strips, United States, Average Price ($),
Historic, 2000-2007 55
Figure 29: Blood Glucose Test Strips, United
States, Average Price ($), Forecast, 2007-2012 56
Figure 30: Glucose
Monitoring, United States, Distribution Share (%), 2006 57
Figure 31:
Glucose Monitoring, United States, Company Share (%), 2006 58
Figure 32:
Insulin Delivery, United States, Overall Revenues ($ mn), Historic, 2000-2007
59
Figure 33: Insulin Delivery, United States, Overall Revenues ($ mn),
Forecast, 2007-2012 60
Figure 34: Insulin Delivery, United States, Revenue
by Segment ($ mn), Historic, 2000-2007 61
Figure 35: Insulin Delivery,
United States, Revenue by Segment ($ mn), Forecast, 2007-2012 62
Figure
36: Insulin Syringes, United States, Overall Revenues ($ mn), Historic,
2000-2007 63
Figure 37: Insulin Syringes, United States, Overall Revenues
($ mn), Forecast, 2007-2012 64
Figure 38: Insulin Pumps, United States,
Overall Revenues ($ mn), Historic, 2000-2007 65
Figure 39: Insulin Pumps,
United States, Overall Revenues ($ mn), Forecast, 2007-2012 66
Figure 40:
Insulin Pens, United States, Overall Revenues ($ mn), Historic, 2000-2007
67
Figure 41: Insulin Pens, United States, Overall Revenues ($ mn),
Forecast, 2007-2012 68
Figure 42: Insulin Jet Injectors, United States,
Overall Revenues ($ mn), Historic, 2000-2007 69
Figure 43: Insulin Jet
Injectors, United States, Overall Revenues ($ mn), Forecast, 2007-2012 70
Figure 44: Insulin Syringes, United States, Overall Volume (Units), Historic,
2000-2007 72
Figure 45: Insulin Syringes, United States, Overall Volume
(Units), Forecast, 2007-2012 73
Figure 46: Insulin Pumps, United States,
Overall Volume (Units), Historic, 2000-2007 74
Figure 47: Insulin Pumps,
United States, Overall Volume (Units), Forecast, 2007-2012 75
Figure 48:
Insulin Pens, United States, Overall Volume (Units), Historic, 2000-2007
76
Figure 49: Insulin Pens, United States, Overall Volume (Units),
Forecast, 2007-2012 77
Figure 50: Insulin Jet Injectors, United States,
Overall Volume (Units), Historic, 2000-2007 78
Figure 51: Insulin Jet
Injectors, United States, Overall Volume (Units), Forecast, 2007-2012 79
Figure 52: Insulin Jet Injectors, United States, Average Price ($), Historic,
2000-2007 80
Figure 53: Insulin Jet Injectors, United States, Average
Price ($), Forecast, 2007-2012 81
Figure 54: Insulin Pens, United States,
Average Price ($), Historic, 2000-2007 82
Figure 55: Insulin Pens, United
States, Average Price ($), Forecast, 2007-2012 83
Figure 56: Insulin
Pumps, United States, Average Price ($), Historic, 2000-2007 84
Figure 57:
Insulin Pumps, United States, Average Price ($), Forecast, 2007-2012 85
Figure 58: Insulin Syringes, United States, Average Price ($), Historic,
2000-2007 86
Figure 59: Insulin Syringes, United States, Average Price
($), Forecast, 2007-2012 87
Figure 60: Insulin Delivery, United States,
Distribution Share (%), 2006 88
Figure 61: Insulin Delivery, United
States, Company Share (%), 2006 89
Figure 62: F. Hoffmann-La Roche
Ltd., Value Chain Analysis 94
Figure 63: Abbott Laboratories, Value
Chain Analysis 115
Figure 64: Becton, Dickinson and Company, Value
Chain Analysis 143
Figure 65: Medical Equipment Approval Process in the
United States, 2007 154
Figure 66: PMA Approval Process in the United
States, 2007 156
Figure 67: The 510(k) Approval Process for Medical
Devices in the United States, 2007 157
Figure 68: Reimbursement Structure
in the United States, 2007 162
Figure 69: Distribution Structure of
Medical Equipment in the United States, 2006 163
Figure 70: Global Markets
Direct Methodology 210
医療機器
その他のカテゴリ
FAQ